Jane Hiatt joined Merck in 1999 and is currently the Executive Director, Site Management and Monitoring and Early Stage Development. She is responsible for the monitoring organization in the US across a diverse portfolio and the clinical trial execution within the Phase 1 Portfolio. Jane’s background includes over 30 years of drug experience in CRO and large pharma environments, starting in data management followed by progressive roles in clinical trial operations and management. She is a
member of ACRP and SCRS.